CD8A and neoplasm: Additionally, in a cohort of patients with non-epithelioid MPM, it has been observed that despite the presence of a high number of anti-tumoral CD8+ T lymphocytes, when a significant level of CD68+ macrophages and PD-L1+ tumor cells are present as well, the response to chemotherapy and the outcome are poor [93].